drugset / Trial / NCT02252692

Relative Bioavailability Study With Enalapril in Healthy Volunteers

NCT02252692

Phase 1 Unknown 24 enrolled Ethicare GmbH European Commission · collab
RandomizedCrossoverOpen-labelTreatment

Summary

Phase I study in healthy adult male and female volunteers to compare the bioavailability of enalapril administered in orodispersible Minitablets with or without water in comparison to the standard galenic tablet formulation of enalapril. The standard pharmacokinetic parameters will be calculated from the bioanalytical results for enalapril and enalaprilat and compared in a descriptive statistical analysis.

Timeline

Start
2014-08
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Enalapril Other / unclassified 10 mg Oral

Indications